Reaction Details |
| Report a problem with these data |
Target | Cholecystokinin receptor type A |
---|
Ligand | BDBM50245193 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_513420 (CHEMBL976507) |
---|
IC50 | 0.45±n/a nM |
---|
Citation | Berger, R; Zhu, C; Hansen, AR; Harper, B; Chen, Z; Holt, TG; Hubert, J; Lee, SJ; Pan, J; Qian, S; Reitman, ML; Strack, AM; Weingarth, DT; Wolff, M; Macneil, DJ; Weber, AE; Edmondson, SD 2-Substituted piperazine-derived imidazole carboxamides as potent and selective CCK1R agonists for the treatment of obesity. Bioorg Med Chem Lett18:4833-7 (2008) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Cholecystokinin receptor type A |
---|
Name: | Cholecystokinin receptor type A |
Synonyms: | CCK-A receptor | CCK-AR | CCK1-R | CCKAR | CCKAR_HUMAN | CCKRA | Cholecystokinin receptor | Cholecystokinin receptor type A | Cholecystokinin-1 Receptor |
Type: | G Protein-Coupled Receptor (GPCR) |
Mol. Mass.: | 47859.34 |
Organism: | Homo sapiens (Human) |
Description: | Stable expression of human CCK-1 receptors in HEK 293 cells. |
Residue: | 428 |
Sequence: | MDVVDSLLVNGSNITPPCELGLENETLFCLDQPRPSKEWQPAVQILLYSLIFLLSVLGNT
LVITVLIRNKRMRTVTNIFLLSLAVSDLMLCLFCMPFNLIPNLLKDFIFGSAVCKTTTYF
MGTSVSVSTFNLVAISLERYGAICKPLQSRVWQTKSHALKVIAATWCLSFTIMTPYPIYS
NLVPFTKNNNQTANMCRFLLPNDVMQQSWHTFLLLILFLIPGIVMMVAYGLISLELYQGI
KFEASQKKSAKERKPSTTSSGKYEDSDGCYLQKTRPPRKLELRQLSTGSSSRANRIRSNS
SAANLMAKKRVIRMLIVIVVLFFLCWMPIFSANAWRAYDTASAERRLSGTPISFILLLSY
TSSCVNPIIYCFMNKRFRLGFMATFPCCPNPGPPGARGEVGEEEEGGTTGASLSRFSYSH
MSASVPPQ
|
|
|
BDBM50245193 |
---|
n/a |
---|
Name | BDBM50245193 |
Synonyms: | (1-(3-ethoxyphenyl)-2-p-tolyl-1H-imidazol-4-yl)(4-(quinolin-3-yl)piperazin-1-yl)methanone | CHEMBL453083 | CHEMBL503822 |
Type | Small organic molecule |
Emp. Form. | C32H31N5O2 |
Mol. Mass. | 517.6208 |
SMILES | CCOc1cccc(c1)-n1cc(nc1-c1ccc(C)cc1)C(=O)N1CCN(CC1)c1cnc2ccccc2c1 |
Structure |
|